CHECKPOINT KINASE 2 GENE MUTATION

This adverse event was reported 7 times

CHECKPOINT KINASE 2 GENE MUTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIROGACESTAT 1 0.0011
1 TALAZOPARIB 1 0.0005
2 ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) 1 0.0004
3 GOSERELIN 2 0.0001
4 ANASTROZOLE TABLETS 1 0.0000
5 ANASTROZOLE 1 0.0000
6 FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE 1 0.0000
7 HYDROXYCHLOROQUINE SULFATE 1 0.0000
8 DENOSUMAB 1 0.0000
9 METHOTREXATE SODIUM 1 0.0000
See all drugs enriched for association with CHECKPOINT KINASE 2 GENE MUTATION

These drug classes are most commonly taken by patients reporting CHECKPOINT KINASE 2 GENE MUTATION:

# Drug class Count
0 Aromatase Inhibitor [EPC] 1
1 Estrogen [EPC] 1
2 Folate Analog Metabolic Inhibitor [EPC] 1
3 Gamma Secretase Inhibitor [EPC] 1
4 RANK Ligand Inhibitor [EPC] 1
See all common drug classes associated with CHECKPOINT KINASE 2 GENE MUTATION

CHECKPOINT KINASE 2 GENE MUTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Gamma Secretase Inhibitor [EPC] 1 0.0011
1 Aromatase Inhibitor [EPC] 1 0.0000
2 Estrogen [EPC] 1 0.0000
3 RANK Ligand Inhibitor [EPC] 1 0.0000
4 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with CHECKPOINT KINASE 2 GENE MUTATION